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1. Introduction 
A stress response is an evolutionary heritage of ability to anticipate, identify and effectively 
respond to danger. After millions of years of evolution, perception of variety of stressors 
mobilizes neurologic, neuroendocrine, endocrine, immunologic and metabolic systems to 
maintain an ability to survive and propagate gens (natural selection). Additionally, in 
humans these mechanisms involve complex and interrelated mental, emotional, behavioral 
and social processes. Behavioral adaptation is aimed on modulation of neural pathways that 
help to cope with stressful situations. These e.g. include changes of sensory thresholds, 
increased alertness, memory enhancement, suppression of hunger, and stress-induced 
analgesia. 
A stressor can be defined as a certain stimulus of the external or internal receptor. The 
stressors are usually divided into macroscopic threats (e.g. fight with enemy, fear, pain) and 
microscopic threats (targeting at epithelial or endothelial barriers e.g. infection or tissue 
damage). These neuroendocrine – immunologic interrelations are also vital in the clinical 
situations. During an acute stress response, physiological processes are aimed on 
redistribution of energy utilization in specific organs, inhibiting or stimulating energy 
mobilization. Therefore certain tissues receive sufficient supply of energy while others 
reduce their consumption according to priority. This is achieved mainly by: the sympathetic 
nervous system (SNS), release of catecholamines which inhibit insulin release and action, 
stimulates glucagon and ACTH production; hypothalamic – pituitary – adrenocortical 
(HPA) axis that in general increases gluconeogenesis and glycogenolysis, inhibits glucose 
uptake, and enhances proteolysis and lipolysis; hypothalamic - posterior pituitary (ADH) – 
kidney axis with water retention; brain – juxta-gromelular apparatus activity - (renin/ 
angiotensin/aldosterone - RAAS) with many effects on blood pressure, electrolytes and 
water balance; hypothalamic-pituitary-thyroid axis (response to cold and heat), natriuretic 
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peptides, the parasympathetic nervous system (acetylcholine release), changes in immune 
system (cytokines and other pro-inflammatory substances), mediators of endothelial 
function and mobilization of stem cells.   
In the clinical settings, variety of interesting models and complex relations can be 
investigated. In particular, pathophysiology and treatment of congenital heart defects create 
unique models of stress response. Hypoxia, circulatory insufficiency, volume or pressure 
overload, hypo- or hyperthermia, pain, changes in organ perfusion, disturbances of the 
osmolarity, inflammatory- or immune- response create exceptional milieu and environment 
for the research.  
In this chapter we reviewed main concepts of stress response in such environment 
additionally presenting some results of own research. It focuses on patients who had strong 
stressors working in acute or chronic manner (desaturation, increased afterload, volume 
overload, circulatory insufficiency) with all related elements affecting the model in clinical 
environment. 
2. The arrangement of the stress response 
The stress response is the complex process that can be initiated by immune or central 
nervous system. The central nervous system reacts against macroscopic threats and controls 
whole body response. Thus, in face of lacking of the system integrity central nervous system 
switches all functions over to subordinate constitutive activities to defense against the 
threat. The hypothalamus – pituitary – adrenal axis is activated and vasopressin, prolactin 
and growth hormone are released. In clinical settings corticotropin realizing hormone and 
vasopressin (both stimulated by adreno-cortical signals e.g. pain, fear, hypovolemia or 
immunologic stimuli e.g. interleukins, TNF, cytokines) (1) synergistically increase 
adrenocorticotropin  (ACTH) secretion.  ACTH induces conversion of cholesterol to cortisol 
which cooperates with sympathetic nervous system to prepare a body for response by 
mobilization of energetic substrates, increase of intravascular volume and blood pressure 
enhancement (Tab.1.). 
The immune system reacts against microscopic threats infringing endothelial or epithelial 
barriers. The initial signal is amplified by cascade of lymphokines and activated cells and 
stimulates central stress response which eventually terminates system overstimulation. 
Immune response and tissue damage contribute to systemic inflammatory response 
syndrome (SIRS) development. These inflammatory signals are transferred to the central 
nervous system by vagus nerve and activate HPA axis (2).  
Adaptation to chronic stress in humans is not well understood and unnatural situation. It is 
mostly created in the clinical settings when treatment of critical disease is implemented and 
it reaches chronic phase. After acute stress response when ACTH, prolactin, growth 
hormone, and thyroid hormone are elevated, the pulsatile, more physiologic pattern of 
neurohormones concentration appears. Although normal limits of plasma neurohormons 
levels in stress response are not known, inadequate concentrations can lead to acute failure 
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Action Mechanism 
Growth inhibition Decrease of DNA and RNA synthesis 
Increase of protein catabolism in all tissues 
Enhancement of protein synthesis in the 
liver 
Substrates availability increase Glycolysis, lipolysis, protein hydrolysis  
Blood pressure increase  Vascular tone increase,  
Expression of adrenergic receptors 
Activation of renin – angiotensin – 
aldosterone system 
Inhibition of constitutive functions Suppression of immune response 
Decrease of circulating lymphocytes, 
monocytes and eosinophils 
Apoptosis induction 
Anti-inflammatory  Decrease of capillary permeability, 
phagocytosis, leucocyte demargination, 
interleukine synthesis   
 
Water balance Sodium and water  reabsorbtion 
Table 1. Role of the cortisol in stress response initiation.  
3. Sympathetic nervous system 
Sympathetic nervous system stimulation is a part of central regulatory mechanism. It exerts 
many effects on the cardiovascular system by norepinephrine and epinephrine. Afferent 
baroreceptor signaling to the brain signals low cardiac output and efferent sympathetic 
pathways are activated. The main results of it are vasoconstriction (increased afterload, 
decreased renal perfusion), increased heart rate and contractility (increased cardiac output 
and wall stress), activation of RAAS. These effects are aimed on restoration of cardiac output, 
however, at the expense of increased myocardial oxygen demand, increased intracellular 
calcium toxicity, and myocardial hypertrophy. Sympathetic overstimulation can cause many 
undesirable effects like: expression of fetal gens, apoptosis, necrosis and remodeling and high 
levels of plasma norepinephrine are an independent predictor of mortality. 
In clinical model of univentricular circulation characterized by increased afterload and normal 
saturation interesting behavioral adaptation was observed. During the exercise the heart rate at 
anaerobic threshold was significantly slower and patients’ lung tidal volume lower compared to 
healthy age matched volunteers. These differences disappeared at peak effort. The effect was 
associated with a delayed chronotropic response of the heart and a reaction which provides a 
longer filling time and larger preload to the single ventricle. Delayed chronotropic response, 
earlier achievement of anaerobic threshold and higher value of ventilator equivalent of carbon 
dioxide at peak exercise obviously reflect greater impairment of cardiac output in single 
ventricle patients compared to healthy volunteers. The limitation of the exercise capacity is 
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caused mainly by abnormal autonomic nervous system activity, lower non-pulsatile pulmonary 
flow, neurohormonal disturbances and dysfunction of the endothelium. The primary 
mechanism restricting exercise capacity is the lack of ability to increase and maintain the cardiac 
output and pulmonary flow in response to exercise. This is complementary with delayed 
chronotropic reaction, decreased heart rate acceleration and abnormal reflex from 
ergoreceptors. Exercise studies with external pacemaker heart stimulation to increase heart rate 
despite of slowing it reflex did not cause increase of exercise tolerance (3). In our model heart 
rate was significantly lower at anaerobic threshold indicating delayed chronotropic response or 
adaptation to the demand of increased output generation (the slower the heart rate, the better 
preload). This was accompanied by significant respiratory tidal volume lowering, diminished 
carbon dioxide production, and respiratory equivalent of carbon dioxide compared to control 
group. These differences disappeared at peak exercise suggesting maintenance of optimal 
hemodynamic and respiratory parameters for maximal physiological effect.  
 
Effects of sympathetic stimulation Cellular effects 
Heart 
Increased contractility (inotropy)  
Increased heart rate  
Increased wall stress 
Decreased myocardial relaxation 
(lusitropy) 
Increased oxygen demand  
Peripheral  vessels 
Constriction 
Increased afterload 
Kidney 
Vasoconstriction 
Sodium retention 
Water retention 
RAAS activation 
Sodium retention 
Water retention 
Increased cardiomyocyte calcium entry 
Myocardial hypertrophy 
Gene expression: 
Increased expression of fetal gens 
Decreased expression of calcium 
metabolism gens 
Apoptosis 
Necrosis 
Fibrosis 
Myocardial hypertrophy / remodeling 
β1 -  receptors down-regulation 
Table 2. Sympathetic nervous system activation 
Significant positive correlation of VE/VCO2 (respiratory equivalent of carbon dioxide) at 
peak exercise with proBNP and endothelin-1 were found. The parameter VE/VCO2 reflects 
relationship between minute ventilation and carbon dioxide clearance and is considered as a 
more sensitive prognostic factor than oxygen consumption in diagnosis of circulatory 
insufficiency. In patients with chronic heart failure VE/VCO2 is increased and negatively 
correlated with cardiac output at peak exercise and is independent of subject effort and 
peripheral function (3, 4). In our study VE/VCO2 peak is significantly higher in investigated 
group, compared to age matched controls. The correlation with endothelin-1 and proBNP 
indicates the possibility of identification of such patients by neurohormonal screening tests 
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and suggests etiology of such condition. Higher concentration of endothelin-1 reveals 
endothelial dysfunction and can contribute to higher resistance of pulmonary vascular bed 
and lower pulmonary blood flow at peak exercise. Higher BNP concentrations can indicate 
more pronounced ventricular dysfunction (5).  
4. Hypothalamic-pituitary-adrenal axis 
Hypothalamic – pitutitary – adrenal system is the central stress response system linking 
neural regulation to neurohormonal and humoral control. In response to cortical signals e.g. 
fear, pain, deep emotions or immune derived factors like TNF α, Il-6 corticotropin realizing 
hormone, vasopressin, prolactin and growth hormone are released. Corticotropin releasing 
hormone stimulates sympathetic system and ACTH secretion. It reaches the adrenal cortex 
and stimulates cortisol production from cholesterol. Cortisol cooperates with sympathetic 
activation to prepare metabolism for stress response. These mechanism inhibit all growth 
and developmental functions, prepare metabolic substrates (glucose, fatty acids, amino 
acids), increase blood pressure and intravascular volume. 
There is insufficiency of hypothalamic-pituitary-adrenal axis after pediatric cardiac surgery 
observed, best described as a critical illness–related corticosteroid insufficiency (CIRCI). Together 
with other axes derangement it is considered as one of the causes of low cardiac output 
syndrome in postoperative period. Many causes of this phenomenon were proposed: brain 
hypoperfusion, central hypothalamus and pituitary gland insufficiency, tissue resistance to 
adrenocorticotropic hormone (ACTH), adrenal dysfunction, cyanosis and tissues immaturities.  
5. Endotheline 
Endothelins (ET -1,-2,-3) are a molecules produced by endothelium acting as a 
vasoconstrictors and mitogenic factors. In patients with heart failure their plasma 
concentrations are increased their concentration is proportional to the severity of the 
disease. Endothelins promote vasoconstriction, inflammation, fibrosis, and hypertrophy in 
the pulmonary and systemic vasculature.  
Plasma ET-1 levels are elevated in patients who have cardiomyopathy or chronic heart 
failure, and correlate with severity and prognosis. In particular, the degree of plasma 
elevation of endothelin correlates with the magnitude of alterations in cardiac 
hemodynamics and functional class. 
In our material, higher pulmonary artery resistance was related to higher endothelin 
concentration in patients with single ventricle, therefore endothelin receptor antagonist 
could result in reduction of pulmonary resistance. 
6. Renin angiotensin aldosterone axis 
Renin angiotensin aldosterone axis exerts many effects in cardiovascular system. Neural 
connexion of the brain and kidneys is stimulated by low sodium, decreased perfusion, 
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increased alpha – adrenergic activity. It can effect juxtaglomerular apparatus increasing 
renien - protease transforming angiotensinogen to angiotensin I which is converted within 
the endothelial cells (particularly concentrated in the lungs) to angiotensin II by angiotensin-
converting enzyme (ACE). Angiotensin II is the most potent vasoconstrictor increasing 
vascular resistance in stress situations (especially in hypovolemia) and effecting adrenal 
cortex increasing aldosterone production which increases reclaiming of sodium and water. 
And its major role is to maintain the circulating volume status. 
7. Vasopressin system 
Vasopressin (ADH) is released by the hypothalamus as a result of baroreceptor, osmotic, 
and neurohormonal stimuli. It normally maintains body fluid balance, vascular tone, and 
regulates contractility.  Heart failure causes a paradoxical increase in AVP. The increased 
blood volume and atrial pressure in heart failure suggest inhibition of vasopressin secretion, 
but it does not occur. This phenomenon is related to SNS and RAAS activation overriding 
the volume and low-pressure cardiovascular receptors and osmotic vasopressin regulation 
causing increase in AVP secretion. It contributes to the increased systemic vascular 
resistance (V1 receptors) and to renal retention of fluid (V2 receptors). Stimulation of V1 
receptors can also case vasoconstriction of the peripheral vessels, platelet aggregation, and 
adrenocorticotrophic hormone stimulation. Low-dose arginine infusion initiated in the 
operating room after complex neonatal cardiac surgery was associated with decreased fluid 
resuscitation and catecholamine. The vasopressin levels are usually high in the early phase 
of septic shock, but it’s deficiency was noted in vasodilatory shock. 
The important mechanism of vasopressin action in stress states is its potentiating effect on 
ACTH secretion leading to cortisol release. Although vasopressin is a powerful 
vasoconstrictor it dilates the pulmonary, cerebral, and myocardial circulations helping to 
preserve vital organ blood flow. 
In our group of patients with single ventricle, there was a significant correlation between 
vasopressin concentration and disturbances of water – electrolyte balance in single ventricle 
patients. Higher vasopressin plasma levels were connected with greater propensity for fluid 
retention and prolonged pleural effusions (6).  
8. Thyroid hormones 
Thyroid hormones are stimulated by TSH anterior pituitary secretion. There is many actions 
of thyroid hormones on cardiovascular system exerted mainly by triiodothyronine (T3). 
These effects can be divided into genomic and extragenomic actions. T3 bounds to the 
nuclear receptors and activates many gens corresponding to key myocardial functions: 
myosin heavy chain (MHC), sarcoplasmic reticulum Caţţ-ATPase (SERCA2) and its 
inhibitor phospholamban (affecting cardiac contractile function and diastolic relaxation), 
voltage-gated Kţ channels, b1-adrenergic receptor, guanine nucleotide regulatory proteins, 
adenylate cyclase, NAţ/Kţ-ATPase, and Na/Ca exchanger. The main cardiovascular effects 
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of T3 are: increased cardiac contractility, reduction of afterload, reduction of vascular 
resistance, chronotropic effect (increased heart rate), increases sodium reabsorption and 
water improves atrial filing pressure. All of this increase cardiac output.  
T3 has genomic effects that maintain endothelial integrity, such as angiotensin receptors in 
vascular smooth muscle cells (VSMC). This supports the hypothesis that the vasculature is a 
principal target for T3 action. T3 decreases resistance in peripheral arterioles. Extragenomic 
actions include: modulation of cellular metabolic activities, such as glucose and amino acid 
transport, ion fluxes at the level of the plasma membrane, and mitochondrial gene 
expression and function.  
9. Cholinergic pathway 
Together with the stimulation of the adrenergic system the feedback is also started as anti-
inflammatory cholinergic pathway. It is comprised of vagus nerve signals leading to 
acetylcholine interaction with receptors on monocytes and macrophages, resulting in 
reduced cytokine production.  It can prevent tissue injury and improve survival by external 
stimulation. The cholinergic anti-inflammatory pathway exerts a tonic, inhibitory influence 
on immune responses to infection and tissue injury. Interrupting this pathway, produces 
exaggerated responses to bacterial products and injury. 
10. Natruretic peptydes 
Natruretic peptide system counteracts of some of the effects of neurohormonal activation 
causing vasodilatation, reduction of aldosterone production (by direct influence on the 
adrenal gland), increased diuresis and natriuresis, reduction of renin production,  decreased 
vasopressin realize, decreased activation of the sympathethic nervous system. Direct 
influence of the naturetic peptydes on the myocardium includes prevention of hypertrophy 
and reduction of fibroblast proliferation. BNP is a natriuretic peptide released in response to 
ventricular volume expansion and pressure overload.  
Cardiopulmonary by-pass in children induces renal and neurohormonal changes similar to 
those observed in congestive heart failure: upregulation of the RAA axis, increase of renin 
concentration, release of vasopressin. The endogenous biological activity of natriuretic 
hormone system is decreased after the bypass. This is caused by deficiency of biologically 
active neurohormons, presence of inactive neurohormons, resistance to natriuretic hormone 
activity, receptor down-regulation, abnormal signal transduction, increased 
phosphodiesterase activity.   
It has been also shown that neurohormons can decrease ischemia-reperfusion injury in 
multiple tissue including heart by inhibition of angiotensin II and aldosterone, limitation of 
intracellular Ca++ overload, maintainance of ATP stores, preservation of myofibril, 
mitochondrial and nuclear structure of cardiomyocytes.  
In the natural history of diseased cardiovascular system complex interactions between local, 
humoral, and neural factors lead to abnormalities in the circulatory control. These adaptive 
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responses are aimed at maintaining adequate vital organ perfusion but can lead to 
unfavorable and undesirable changes both in the heart and the vascular system. An 
impaired regulation of cardiac autonomic system and activation of many neurohormonal 
factors as well as the rennin-angiotensin-aldosterone system (RAAS). These changes may 
contribute to numerous early and late complications e.g. dysregulation of fluid homeostasis, 
effusions, detrimental remodeling, protein-losing enteropathy and limited exercise capacity. 
They can also serve as important indices for risk stratification, prediction of unfavorable 
events and adjustment of treatment (3). 
LAP
 
Figure 1. Natruretic factors interactions. 
11. Stem cells   
Stem cells are specific cells with ability to unlimited divisions and differentiation. There are 
many types of stem cells depending on the differentiation degree. Residual small cells with 
embryonic stem cells phenotype (VSELs, Very Small Embryonic-like Cells) are a population of 
pluripotent cells deposited in developing organs during embryogenesis. In the bone marrow 
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VSELs find beneficial conditions to growth and become reserve cell line participating in 
tissue and organ regeneration. In the postnatal life they are inactive and flow in blood 
stream in small amount. Mobilization of VSEL’s is considered as a part of stress response it 
can increase upon different impulses e.g. tissue damage, ischemia, hypoxia, myocardial 
infarction, open heart surgery, extracorporeal circulation. Cells mobilized from bone 
marrow penetrate to blood and are attracted to damaged tissues by chemotactic factors, e.g. 
SDF-l, HGF/SF, or VSEGF.  
Researches who identified and described morphology of VSELs also showed the ability of 
those cells to proliferate and differentiate into all three primary germ layers in appropriate 
differentiating medium. It has been also proved that VSELs express many markers of 
primordial germ cells, e.g. fetal alkaline phosphatase,  Oct-4, SSEA-l, CXCR4, Mvh, Stella, 
Fragilis, Nobox and Hdac6, indicating their similarity to germ cells through which genes are 
passed from generation to generation – the best reservoir of stem cells (7, 8). Most active 
translocation of stem cells takes place during early stage of human embryogenesis. In the 
beginning of gastrulation and organogenesis stem cells migrate to places of new tissues and 
organs formation. Subsequently, stem cells settle down in tissue specific spaces and 
constitute a cell line undergoing self-renewal process. These cells also replenish damaged or 
apoptotic cells during individual life. VSELs may accumulate in bone marrow under the 
influence of chemotactic factors (correlation between CXCR4 receptor and lymphokine SDF-
1). After colonizing bone marrow VSELs find beneficial conditions to growth and become 
reserve cell line participating in tissue and organ regeneration. In normal conditions VSELs 
circulate in the peripheral blood in small number and can increase upon different stimuli 
e.g. tissue damage or severe stress (ischemia, hypoxia, myocardial infarction, open heart 
surgery, extracorporeal circulation) (9). Cells mobilized from bone marrow penetrate to 
blood and are attracted to damaged tissues by chemotactic factors, e.g. SDF-l, HGF/SF, or 
VSEGF. It has been proved that many clinical scenarios are associated with increase of stem 
cells in bloodstream. Increase of the number of bone marrow derived stem cells was 
observed in skeletal muscle injury, myocardial infarction, stroke, bones fractures, leasions of 
the liver and kidneys, ischaemia of the extremities and after lung or liver transplantation. 
These cells were described as endothelial progenitor cells (EPC), myocardial or muscle 
progenitor cells, neural progenitor cells, liver progenitor cells etc… These data indicate that 
during injury of the tissues and organs non-hematopoetic stem cells are mobilized from the 
marrow (10) and probably from other tissue niches to the blood where they circulate as a 
source of the stem cells supporting regeneration of the tissues (11, 12). This process is 
governed by injured tissue derived chemoattractants such as SDF-l, and other factors e.g.: 
VEGF, HGF/SF, UF and FGF-2. It is also known that transcriptional factor HIF-1 (hypoxia 
regulated/induced transcription factor) connected with the tissue ischemia takes important 
palce in regulation of expression of these factors. The promotor for sdf-l, vegf and hgf/sf 
gens have bounding places for HIF-1. Therefore hypoxia / cyanosis can induce expression of 
factors responsible for stem cells releasing and their migration to the injured tissues and 
organs. VSELs which are present in the marrow are quiescent and they need unknown 
factors for activation and stimulation of their activity. These incentives and modulators are 
unknown. 
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Recent research indicates that in the mature hearts of the mammalians there is a population 
of the cells capable of mitotic divisions named cardiac stem cells (CSC). They are 
pluripotential, clonogenic, and self-replicable. Their location in the herat seems to be related 
to the mechanical load of given segment of the heart muscle and is inversely proportional to 
hemodynamic load. The number of CSC depends on the methodology of counting and 
ranges from 1/8000 to 1/20 000 cardiomyocytes or 1/ 32 000 – 1/80 000 all cells of the heart. 
Figure 2. Flow cytometry – mobilization of VSELs in children undergoing heart surgery due to 
congenital heart diseases 
In population of our patients we’ve obtained blood specimens before the operation and 
during the hospitalization to determine the level of VSELs mobilization. Using the flow 
cytometry it has been shown that VSELs appears in peripheral blood with a specified 
pattern of mobilization during surgery and directly after it (Fig.2.) and confirmed the 
presence of those cells within myocardium Fig.3. 
The acute phase of stress response is characterized by increased release of neuroendocrine 
mediators from the hypothalamus and pituitary. This is aimed on the blood pressure 
maintenance and mobilization of fuel substrates at the expense of deregulation of 
homeostatic mechanisms, immunologic response, growth, development and regeneration. If 
stress response is insufficient to maintain tissue perfusion, shock appears.  
During the prolonged phase of critical illness, the effects of the stress response mediators, 
may be harmful. Decreased levels of anterior pituitary hormones and loss of the normal 
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pattern of pulsatile release of these hormones characterize the prolonged phase of critical 
illness.  Cortisol levels remain elevated in chronic critical illness despite a decrease in ACTH 
release. The metabolic result of this neuroendocrine array is worsen metabolism of fatty 
acids and a propensity for fat storing and protein wasting. The immune effects related to 
neuroendocrine disturbances are impaired lymphocyte and monocyte function and 
increased lymphocyte apoptosis. It leads to catabolic state and multiple organ dysfunction. 
Duration of immune suppression correlates strongly with the incidence of related infection. 
Tissue damage and strong stressors (such as cyanosis, circulatory insufficiency) stimulate 
regenerative and reparative processes involving stem cells. 
Figure 3. Very small embryonic-like cells extracted from the heart 
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